http://orcid.org/0000-0002-2864-4073
References
- Galanello R, Origa R. β-thalassemia. Orphanet J Rare Dis. 2010;5:11.
- van den Akker E, Satchwell TJ, Pellegrin S, et al. The majority of the in vitro erythroid expansion potential resides in CD34(–) cells, outweighing the contribution of CD34(+) cells and significantly increasing the erythroblast yield from peripheral blood samples. Haematologica. 2010;95(9):1594–1598.
- Kuijpers TW, Tool ATJ, van der Bijl I, et al. Combined immunodeficiency with severe inflammation and allergy caused by ARPC1B deficiency. J Allergy Clin Immunol. 2017;140(1):273–277.e10.
- Joly P, Szymanowicz A, Neyron MJ, et al. Hb Charlieu [α106(G13)Leu→Pro (α1)]: a new phenotypically silent hemoglobin variant associated with a mild α-thalassemia phenotype. Hemoglobin. 2010;34(4):366–373.
- Hardison RC. Evolution of hemoglobin and its genes. Cold Spring Harb Perspect Med. 2012;2(12):a011627.
- Ribeil JA, Arlet JB, Dussiot M, et al. Ineffective erythropoiesis in β-thalassemia. ScientificWorldJournal. 2013;2013:394295.
- Mettananda S, Gibbons RJ, Higgs DR. α-Globin as a molecular target in the treatment of β-thalassemia. Blood. 2015;125(24):3694–3701.
- Weatherall DJ. Phenotype-genotype relationships in monogenic disease: lessons from the thalassaemias. Nat Rev Genet. 2001;2(4):245–255.
- Lacerra G, Scarano C, Musollino G, et al. Hb Foggia or α117(GH5)Phe→Ser: a new α2 globin allele affecting the α Hb-AHSP interaction. Haematologica. 2008;93(1):141–142.
- Yu X, Mollan TL, Butler A, et al. Analysis of human α globin gene mutations that impair binding to the α hemoglobin stabilizing protein. Blood. 2009;113(23):5961–5969.